BioNTech SE (BNTX) Profit After Tax (2018 - 2025)
BioNTech SE (BNTX) reported Profit After Tax of -$355.0 million for Q4 2025, down 228.03% on a YoY basis from $277.3 million in Q4 2024, and down 958.16% sequentially from -$33.6 million in Q3 2025.
BioNTech SE (BNTX) Profit After Tax (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Profit After Tax data on file, last reported at -$355.0 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 228.03% year-over-year to -$355.0 million; the trailing twelve-month figure through Dec 2025 stood at -$1.3 billion (down 76.14% YoY), and the FY2025 full-year result was -$1.3 billion, down 80.55% from the prior year.
- Profit After Tax eased to -$355.0 million in Q4 2025, from -$33.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $4.2 billion in Q1 2022 to a low of -$869.9 million in Q2 2024.
- A 5-year average of $1.1 billion and a median of $385.0 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax jumped 827987404.69% in 2021 and tumbled 319.57% in 2024, its largest moves.
- Tracing BNTX's Profit After Tax over 5 years: stood at $3.6 billion in 2021, then tumbled by 35.81% to $2.3 billion in 2022, then sank by 78.81% to $492.7 million in 2023, then slumped by 43.72% to $277.3 million in 2024, then sank by 228.03% to -$355.0 million in 2025.
- Business Quant data shows BNTX's Profit After Tax at -$355.0 million in Q4 2025, -$33.6 million in Q3 2025, and -$437.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | -355.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -355.03 Mn |
| Sep 30, 2025 | -33.55 Mn |
| Jun 30, 2025 | -437.62 Mn |
| Mar 31, 2025 | -437.37 Mn |
| Dec 31, 2024 | 277.30 Mn |
| Sep 30, 2024 | 217.56 Mn |
| Jun 30, 2024 | -869.91 Mn |
| Mar 31, 2024 | -342.31 Mn |
| Dec 31, 2023 | 492.67 Mn |
| Sep 30, 2023 | 174.83 Mn |
| Jun 30, 2023 | -207.33 Mn |
| Mar 31, 2023 | 539.03 Mn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 4.15 Bn |
| Dec 31, 2021 | 3.62 Bn |
| Sep 30, 2021 | 3.79 Bn |
| Jun 30, 2021 | 3.36 Bn |
| Mar 31, 2021 | 1.36 Bn |